Instituto de Investigación Sanitaria La Fe-ko ikertzaileekin lankidetzan egindako argitalpenak (49)

2024

  1. Implementation of pharmacogenetics in primary care

    Atencion Primaria

  2. Novel risk loci for COVID-19 hospitalization among admixed American populations

    eLife, Vol. 13

  3. Safe Procedure for Efficient Hydrodynamic Gene Transfer to Isolated Porcine Liver in Transplantation

    International Journal of Molecular Sciences, Vol. 25, Núm. 3

2023

  1. A second update on mapping the human genetic architecture of COVID-19

    Nature

  2. Personalized Medicine in Infant Population with Cancer: Pharmacogenetic Pilot Study of Polymorphisms Related to Toxicity and Response to Chemotherapy

    Cancers, Vol. 15, Núm. 5

  3. Sex Differences in Opioid Response Linked to OPRM1 and COMT genes DNA Methylation/Genotypes Changes in Patients with Chronic Pain

    Journal of Clinical Medicine, Vol. 12, Núm. 10

2022

  1. Metformin to treat Huntington disease: A pleiotropic drug against a multi-system disorder

    Mechanisms of Ageing and Development, Vol. 204

  2. Novel genes and sex differences in COVID-19 severity

    Human molecular genetics, Vol. 31, Núm. 22, pp. 3789-3806

  3. Pharmacogene Variants Associated with Liver Transplant in a Twelve-Year Clinical Follow-Up

    Pharmaceutics, Vol. 14, Núm. 2

  4. Study of Oligonucleotides Access and Distribution in Human Peripheral Blood Mononuclear Cells

    International Journal of Molecular Sciences, Vol. 23, Núm. 10

2021

  1. Foxp3 silencing with antisense oligonucleotide improves immunogenicity of an adjuvanted recombinant vaccine against sporothrix schenckii

    International Journal of Molecular Sciences, Vol. 22, Núm. 7

  2. Impact of combinations of single-nucleotide polymorphisms of anthracycline transporter genes upon the efficacy and toxicity of induction chemotherapy in acute myeloid leukemia

    Leukemia and Lymphoma, Vol. 62, Núm. 3, pp. 659-668

  3. Influence of polymorphisms in anthracyclines metabolism genes in the standard induction chemotherapy of acute myeloid leukemia

    Pharmacogenetics and Genomics, Vol. 31, Núm. 6, pp. 133-139

  4. Mitochondrial dna replacement techniques to prevent human mitochondrial diseases

    International Journal of Molecular Sciences, Vol. 22, Núm. 2, pp. 1-23

  5. Multicompartmental lipopolyplex as vehicle for antigens and genes delivery in vaccine formulations

    Pharmaceutics, Vol. 13, Núm. 2, pp. 1-20

  6. Pharmacogenetics in neuroblastoma: What can already be clinically implemented and what is coming next?

    International Journal of Molecular Sciences, Vol. 22, Núm. 18

2020

  1. Cancer in the first 18 months of life

    Anales de Pediatria, Vol. 93, Núm. 6, pp. 358-366

  2. Gold nanoparticle-assisted virus formation by means of the delivery of an oncolytic adenovirus genome

    Nanomaterials, Vol. 10, Núm. 6, pp. 1-16

  3. MTHFR and VDR polymorphisms improve the prognostic value of MYCN status on overall survival in neuroblastoma patients

    International Journal of Molecular Sciences, Vol. 21, Núm. 8

2019

  1. Colorectal cancer: Pharmacogenetics support for the correct drug prescription

    Pharmacogenomics, Vol. 20, Núm. 10, pp. 741-763